USPTO 2015–2025 USPTO PatentsView US Corporation

Lipocine, Inc.

USPTO PatentsView assignee record - 24 granted patents across 4 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Lipocine ranks #12,524 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 4 technology areas.

#12,524
of 49,997 US assignees by volume
36th percentile
by Innovation Score (31.0/100)
21.3
avg claims per patent
-59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12524 · US Corporation #12,524 · 24 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 24 grants
  • MID-PACK #12,524/49,997
  • PHOTO-FINISH Life Safety…
  • CPC-NARROW A61K · 4 areas
  • INNOV-THIN 31.0/100
  • CLAIMS-DENSE 21.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -59% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Life Safety Distribution AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lipocine’s 31.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Lipocine

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Lipocine's Innovation Score is 31.0/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Lipocine?

Each dot is one of Lipocine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lipocine’s own 21.3 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Lipocine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 23.923.92424.1 51015202530 Granted patents (volume) Avg claims / patent LiTL LLC - 24, 24.58LitlLife Safety Distribution AG - 24, 14.67Life Safety Distr…Life Sciences Research Partners VZW - 24, 13.46Life Sciences Res…Life Services, LLC - 24, 21.42Life ServicesLonati S.P.A. - 24, 9.88Lonati S P ALunera Lighting, Inc. - 24, 6.04Lunera LightingLutron Ketra, LLC - 24, 18.21Lutron KetraLyondellBasell Acetyls, LLC - 24, 14.79Lyondellbasell Ac…Lipocine, Inc. - 24, 21.29Lipocine
Lipocine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lipocine's grants concentrate

Lipocine, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 95.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2019. By volume, Lipocine sits between LiTL LLC and LyondellBasell Acetyls, LLC.

Who files at Lipocine's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Lipocine holds 24 patents at rank #12,531, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Lipocine

By rank, the assignees closest to #12,531 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Lipocine's primary technology class.

Lipocine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201620172018201920202021 2
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Lipocine, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 12.5%
2016 8 33.3%
2017 2 8.3%
2018 3 12.5%
2019 1 4.2%
2020 5 20.8%
2021 2 8.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Lipocine, Inc.'s patent record in context - here's where to go next.

  • Lipocine, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 95.8% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #12,524 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Lipocine, Inc. against LiTL LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.